company

NORSK FORENING FOR TUBERØS SKLEROSE COMPLEX

5962 BJORDAL

Return on Equity
−50,68 %
Current Ratio
25,56
Debt-to-Equity Ratio
0
Key figures (NOK)2018
Revenue497 000
Net Income−336 000
Total Assets690 000
Total Equity663 000
Income (NOK)2018
Revenue497 000
Expenditure841 000
Operating Profit−345 000
Financial Income9 000
Financial Costs0
Financial Balance9 000
Earnings Before Tax−336 000
Tax0
Net Income−336 000
Balance (NOK)2018
Total Fixed Assets0
Total Current Assets690 000
Total Assets690 000
Total Retained Equity663 000
Total Equity663 000
Total Long-Term Debt0
Total Current Debt27 000
Total Equity and Debt690 000
Cash flow (NOK)2018
Sales Income497 000
Other Income0
Revenue497 000
Cost of Goods Sold722 000
Salary Costs0
Depreciation0
Impairment0
Expenditure841 000
Operating Profit−345 000
Financial Income9 000
Financial Costs0
Financial Balance9 000
Dividends0
Net Income−336 000
Balance details (NOK)2018
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank690 000
Total Current Assets690 000
Total Assets690 000
Total Equity663 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors27 000
Unpaid Taxes0
Dividends0
Other Current Debt0
Total Current Debt27 000
Total Equity and Debt690 000
Financial indicators2018
Return on Equity−50,68 %
Debt-to-Equity Ratio0
Operating Profit Margin−69,42 %
Current Ratio25,56
Quick Ratio25,56
Equity Ratio0,96
Gross Profit Margin−45,27 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English